A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
Clinical trial NCT04904471 · COMPLETED
Trial details
- NCT number
- NCT04904471
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2022-01-31
- Enrollment
- 39663
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.